Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
SAN DIEGO, Sept. 21, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) announced today that it will be presenting at the 2018 Cantor Fitzgerald Global Healthcare Conference in New York. ...
-
SAN DIEGO, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) today announced that Dr. Shawn A. Scranton, will be joining Pfenex as its Chief Operating Officer, effective October...
-
SAN DIEGO, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) announced today that it will be presenting at the Liolios 7th Annual Gateway Conference in San Francisco, CA. ...
-
SAN DIEGO, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) announced today that Dr. Hubert Chen has resigned from his role as Chief Medical and Scientific Officer, effective...
-
SAN DIEGO, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) is a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression...
-
SAN DIEGO, July 25, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE AMERICAN:PFNX) a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology®...
-
SAN DIEGO, July 12, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE AMERICAN:PFNX) today announced the receipt of a milestone payment from Merck associated with the initiation of the first Phase 3...
-
SAN DIEGO, June 22, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American:PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression...
-
SAN DIEGO, June 14, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American:PFNX) announced today that it will be presenting at the JMP Securities 2018 Life Science Conference in New York City. ...
-
SAN DIEGO, June 11, 2018 (GLOBE NEWSWIRE) -- Pfenex (NYSE American:PFNX) and Alvogen today announced entering into an agreement granting Alvogen exclusive rights to commercialize Pfenex’s lead drug...